When compared to healthy controls, significantly different serum levels of all the three molecules were found in SSc patients with the active/late NVC pattern, with a decrease in sNRP1 and an increase in both Sema3E and Slit2 (p < 0.001 for all comparisons; Figure 3A–C). Here, SEMA3E is linked to systemic sclerosis.